TrialActa neuropathologica2024

A muscarinic receptor antagonist reverses multiple indices of diabetic peripheral neuropathy: preclinical and clinical studies using oxybutynin.

Carolina M Casselini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.